Over the past 12 months, Supernus Pharmaceuticals insiders sold $10.26 million of stock on the open market (202.09K shares) and made no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jack A. Khattar | President, Ceo | 1,258,351 | 0 | 1,258,351 | 72.6% | 14 Aug, 2026 |
| 2 | Charles W Iii Newhall | Director | 124,119 | 0 | 124,119 | 7.2% | 25 Feb, 2026 |
| 3 | John M Siebert | Director | 87,943 | 0 | 87,943 | 5.1% | 27 Feb, 2024 |
| 4 | Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 86,933 | 0 | 86,933 | 5.0% | 27 Feb, 2024 |
| 5 | Frederick M. Hudson | Director | 60,413 | 0 | 60,413 | 3.5% | 16 Mar, 2026 |
| 6 | Georges Gemayel | Director | 27,277 | 0 | 27,277 | 1.6% | 09 Mar, 2026 |
| 7 | Carrolee Barlow | Director | 27,045 | 0 | 27,045 | 1.6% | 25 Feb, 2026 |
| 8 | Frank Mottola | Svp, Chief Tech. Ops. Officer | 19,544 | 0 | 19,544 | 1.1% | 14 Aug, 2026 |
| 9 | Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | 18,637 | 0 | 18,637 | 1.1% | 14 Aug, 2026 |
| 10 | Jonathan Rubin | Svp, Chief Medical Officer | 13,979 | 0 | 13,979 | 0.8% | 14 Aug, 2026 |
| 11 | Timothy C Dec | Senior Vice President Cfo | 9,129 | 0 | 9,129 | 0.5% | 14 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 12 Aug, 2026 | Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | Acquired M | 2,500 | $0.00 | $0 | 19,795 | Direct |
| 12 Aug, 2026 | Jack A. Khattar | President, Ceo | Acquired M | 29,849 | $0.00 | $0 | 1,270,993 | Direct |
| 12 Aug, 2026 | Timothy C Dec | Senior Vice President Cfo | Acquired M | 1,250 | $0.00 | $0 | 9,733 | Direct |
| 12 Aug, 2026 | Jonathan Rubin | Svp, Chief Medical Officer | Acquired M | 750 | $0.00 | $0 | 14,342 | Direct |
| 12 Aug, 2026 | Frank Mottola | Svp, Chief Tech. Ops. Officer | Acquired M | 1,650 | $0.00 | $0 | 20,341 | Direct |
| 12 Aug, 2026 | Jonathan Rubin | Svp, Chief Medical Officer | Disposed F | 363 | $46.57 | $16.90K | 13,979 | Direct |
| 12 Aug, 2026 | Frank Mottola | Svp, Chief Tech. Ops. Officer | Disposed F | 797 | $46.57 | $37.12K | 19,544 | Direct |
| 12 Aug, 2026 | Timothy C Dec | Senior Vice President Cfo | Disposed F | 604 | $46.57 | $28.13K | 9,129 | Direct |
| 12 Aug, 2026 | Jack A. Khattar | President, Ceo | Disposed F | 12,642 | $46.57 | $588.74K | 1,258,351 | Direct |
| 12 Aug, 2026 | Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | Disposed F | 1,158 | $46.57 | $53.93K | 18,637 | Direct |
| 12 Aug, 2026 | Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | Disposed M | 2,500 | $0.00 | $0 | 0 | Direct |
| 12 Aug, 2026 | Frank Mottola | Svp, Chief Tech. Ops. Officer | Disposed M | 1,650 | $0.00 | $0 | 0 | Direct |
| 12 Aug, 2026 | Timothy C Dec | Senior Vice President Cfo | Disposed M | 1,250 | $0.00 | $0 | 0 | Direct |
| 12 Aug, 2026 | Jonathan Rubin | Svp, Chief Medical Officer | Disposed M | 750 | $0.00 | $0 | 0 | Direct |
| 12 Aug, 2026 | Jack A. Khattar | President, Ceo | Disposed M | 29,849 | $0.00 | $0 | 0 | Direct |
| 29 Jul, 2026 | Jonathan Rubin | Svp, Chief Medical Officer | Acquired A | 750 | $0.00 | $0 | 750 | Direct |
| 29 Jul, 2026 | Jack A. Khattar | President, Ceo | Acquired A | 29,849 | $0.00 | $0 | 29,849 | Direct |
| 29 Jul, 2026 | Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | Acquired A | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 29 Jul, 2026 | Frank Mottola | Svp, Chief Tech. Ops. Officer | Acquired A | 1,650 | $0.00 | $0 | 1,650 | Direct |
| 29 Jul, 2026 | Timothy C Dec | Senior Vice President Cfo | Acquired A | 1,250 | $0.00 | $0 | 1,250 | Direct |